SEC Form 10-Q filed by Banc of California Inc.

10-Q - BANC OF CALIFORNIA, INC. (0001169770) (Filer)

8-K - BANC OF CALIFORNIA, INC. (0001169770) (Filer)

8-K - BANC OF CALIFORNIA, INC. (0001169770) (Filer)

Banc of California, Inc. (the "Company") (NYSE:BANC) announced today that its Board of Directors declared a quarterly cash dividend of $0.10 per share on its outstanding common stock. The dividend will be payable January 2, 2025, to stockholders of record as of December 16, 2024. The Board of Directors also declared a quarterly cash dividend of $0.4845 per depositary share on its 7.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series F. The dividend will be payable December 2, 2024, to stockholders of record as of November 21, 2024. The Series F depositary shares are traded on the New York Stock Exchange under the "Banc/PF" symbol. The Company maintains a Dividend Reinvestment

Banc of California, Inc. (NYSE:BANC): $(0.01) Loss Per Share $0.25 Adjusted Earnings Per Share(1) $17.75 Book Value Per Share $15.63 Tangible Book Value Per Share(1) 10.45% CET1 Ratio 28% Average Noninterest-Bearing Deposits to Average Total Deposits Banc of California, Inc. (NYSE:BANC) ("Banc of California" or the "Company"), the parent company of wholly-owned subsidiary Banc of California (the "Bank"), today reported financial results for the third quarter ended September 30, 2024. The Company reported a net loss available to common and equivalent stockholders of $1.2 million, or a loss of $0.01 per diluted common share, for the third quarter of 2024. On an ad

Banc of California, Inc. (the "Company") (NYSE:BANC) today announced it will release 2024 third quarter financial results on Tuesday, October 22, 2024. The Company will host a conference call to discuss its third quarter results at 10:00 a.m. Pacific Time (PT) on the same day. Interested parties are welcome to attend the conference call by dialing (888) 317-6003 and referencing event code 6084667. A link to the live audio webcast and the slide presentation for the call will be available on the Company's investor relations website prior to the call. An audio archive of the conference call will be available on the Company's investor relations website within 24 hours after the end of the call

Stephens & Co. analyst Andrew Terrell maintains Banc of California (NYSE:BANC) with a Equal-Weight and lowers the price target from $15 to $14.

Wedbush analyst David Chiaverini reiterates Banc of California (NYSE:BANC) with a Neutral and maintains $14 price target.

Barclays analyst Jared Shaw maintains Banc of California (NYSE:BANC) with a Equal-Weight and lowers the price target from $15 to $14.

SC 13G - BANC OF CALIFORNIA, INC. (0001169770) (Subject)

SC 13D/A - BANC OF CALIFORNIA, INC. (0001169770) (Subject)

SC 13G/A - BANC OF CALIFORNIA, INC. (0001169770) (Subject)

Chris Hague joins Banc of California as Executive Vice President and Head of Specialty Finance Team includes five others to expand lender finance and additional areas Banc of California, a wholly owned subsidiary of Banc of California, Inc. (NYSE:BANC), announced today that Chris Hague has joined the company as Executive Vice President and Head of Specialty Finance. In this role, Hague oversees the bank's teams in Lender Finance, Asset-Based Lending (ABL), and Corporate Asset Finance and Commercial Aviation (CAF). Hague is also a member of the bank's Senior Management Committee. Hague is based in Chicago and reports to Hamid Hussain, President of the bank. Hague is an industry leader

NEW YORK, Nov. 27, 2023 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Thursday, November 30: Carlyle Group Inc. (NASD: CG) will replace ICU Medical Inc. (NASD: ICUI) in the S&P MidCap 400. ICU Medical will replace PacWest Bancorp (NASD: PACW) in the S&P SmallCap 600. Banc of California Inc. (NYSE:BANC) is acquiring PacWest Bancorp in a deal expected to be completed soon, pending final closing conditions. Post-merger, Banc of California will remain in the S&P SmallCap 600. ICU Medical is more representative of the small-cap market space.WP Carey Inc. (NYSE: WPC) will replace Worthingt

Banc of California, Inc. (NYSE:BANC) (the "Company"), the holding company for Banc of California, N.A. (the "Bank"), today announced the appointment of Joseph Kauder as Executive Vice President and Chief Financial Officer of the Company and the Bank, effective July 10, 2023. Mr. Kauder succeeds Executive Vice President and CFO Lynn Hopkins, who stepped down from the Company effective March 31, 2023. Raymond Rindone, the Company's Deputy CFO and Chief Accounting Officer, will continue to serve as interim Chief Financial Officer until Mr. Kauder joins the Company. "I am thrilled to have Joe join our executive leadership team," said Jared Wolff, Chairman, President & CEO of Banc of Califor